Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 9NET 7Gastrointestinal 2Thoracic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Brain Neoplasms 285Glioblastoma 248Glioma 196Neuroblastoma 86Neoplasms 62Central Nervous System Neoplasms 54Astrocytoma 54Medulloblastoma 47Breast Neoplasms 43Sarcoma 39Meningioma 39Melanoma 38Neurofibromatosis 1 36Lung Neoplasms 36Ependymoma 35Carcinoma, Non-Small-Cell Lung 35Osteosarcoma 31Rhabdomyosarcoma 30Sarcoma, Ewing 27Rhabdoid Tumor 27Neoplasm Metastasis 27Diffuse Intrinsic Pontine Glioma 27Recurrence 26Oligodendroglioma 23Wilms Tumor 21Gliosarcoma 21Pheochromocytoma 20Pancreatic Neoplasms 20Hepatoblastoma 20Meningeal Carcinomatosis 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoid Tumor × CNS × 90 days × Clear all
NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

British Columbia Cancer Agency

Active not recruiting
800 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡